Kimia Biosciences Ltd gets permission to manufacture and sell new API - Brivaracetam

Kimia Biosciences Ltd has been granted 'Permission to manufacture new API for sale or for distribution' namely Brivaracetam by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare, FDA Bhawan, New Delhi - 110002 (India) Vide permission No. MF/SND/21/000036 dated 15-Feb-2021 in FORM CT-22 under Drugs & Cosmetics Acts & Rules thereunder.

Shares of Kimia Biosciences Ltd. was last trading in BSE at Rs.41.7 as compared to the previous close of Rs. 41.1. The total number of shares traded during the day was 583 in over 16 trades.

The stock hit an intraday high of Rs. 42.3 and intraday low of 39.4. The net turnover during the day was Rs. 23879.

Source : Equity Bulls

Keywords